Two Sigma Investments
PSTV

Two Sigma Investments’s Plus Therapeutics PSTV Stock Holding History

Two Sigma Investments’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28
Closed -$3.36K – 3161
2022
Q4 		$3.36K Buy
+28
New +$4.46K ﹤0.01% 2758
2022
Q1 		– Sell
-263
Closed -$104K – 3987
2021
Q4 		$104K Buy
263
+219
+498% +$126K ﹤0.01% 4052
2021
Q3 		$31K Sell
44
-245
-85% -$187K ﹤0.01% 4160
2021
Q2 		$278K Buy
+289
New +$261K ﹤0.01% 3570
2021
Q1 		– Sell
-151
Closed -$114K – 4176
2020
Q4 		$114K Buy
151
+107
+243% +$91.5K ﹤0.01% 3203
2020
Q3 		$42K Buy
+44
New +$42.7K ﹤0.01% 2982
2015
Q2 		– Hold
0
– -$32K – 3034
2015
Q1 		– Hold
0
– – – 2590
2014
Q4 		– Hold
0
– – – 2186
2014
Q3 		– Hold
0
– – – 1702

Other funds holding PSTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments's PSTV Position: Q1 2023 in Review

Two Sigma Investments sold out of Plus Therapeutics (PSTV) in Q1 2023, closing a stake of 28 shares — an estimated $3.36K sold.

Two Sigma Investments first reported a position in PSTV in Q3 2020 and held it in 6 quarters. The position peaked at $278K in Q2 2021. 16 funds tracked by Wall St. Rank hold PSTV as of Q1 2023.

  • Two Sigma Investments reported no remaining Plus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Investments sold 28 Plus Therapeutics shares in Q1 2023, an estimated $3.36K.
  • Two Sigma Investments first reported a position in Plus Therapeutics in Q3 2020 and held it in 6 quarters.
  • Two Sigma Investments's Plus Therapeutics position peaked at $278K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.